Pay in 4 interest-free payments of $5.51 Learn more
Ships within 48 hours · Estimated delivery Aug 12 - Aug 17
The key to consistent dosing is accurate preparation
Some individuals may experience mild injection site reactions, temporary fatigue, or slight headache
MedicalDaily Evidence Check The evidence base for BPC-157, TB-500, and MOTS-C consists of animal studies, small pilot human trials, and anecdotal clinical reports, none of which meet the standard of a Phase 3 randomized controlled trial required for FDA drug approval
Product quality varies dramatically in the peptide market
Your provider may recommend weekly or biweekly sessions to maintain consistent nutrient levels
TB-500 is derived from thymosin beta-4, a naturally occurring peptide involved in actin cytoskeleton regulation and cellular movement, which makes it useful in studies examining cytoskeletal organization and cell motility
US$ 22.14
US$ 25.55
US$ 21.45
US$ 23.21
US$ 20.64
